REmote MOnitoring Transmission Evaluation of IPGs (REMOTE-IPG)
The purpose of this study is to evaluate the potential clinical and economic benefits of using CareLink remote management for pacemaker follow-up.
Study Objectives include:
- To determine clinician perceived quality of care for CareLink remote follow-up.
- To determine patient satisfaction with CareLink follow-up.
- To estimate the time required to perform patient follow-up via CareLink remote transmissions.
- To determine the percentage of regular CareLink follow-ups that do not require further in-clinic review of the patient.
- To estimate potential patient cost avoidance for one year of follow up incorporating CareLink.
- To evaluate compliance to scheduled CareLink transmissions with the remote management system
This is a non-randomized, multi-center, prospective study in which 120 patients who have a pacemaker are enrolled into the study and receive a CareLink monitor. Patients will replace their regularly scheduled pacemaker clinic follow-up visits with a CareLink remote transmission for 12months.
Patients will require a test transmission within 1 month after they receive their CareLink monitor. Afterwards, patients are followed via CareLink transmissions as per their usual clinic schedule for 12 months.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
British Columbia
-
Kelowna, British Columbia, Canada
- Kelowna General Hospital
-
-
Ontario
-
Newmarket, Ontario, Canada
- Southlake Regional Hospital
-
-
Quebec
-
Quebec City, Quebec, Canada
- CHUQ, L'Hotel Dieu de Quebec
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients who have received a market released Medtronic pacemaker with automatic threshold management features for all active leads.
- Patients who have been implanted with their current pacemaker for at least 3 months.
- Patients who are willing, or who have caregivers willing, to use the Medtronic CareLink Monitor.
- Patients who are willing and able to sign an IRB/MEC approved patient informed consent.
Exclusion Criteria:
- Patients participating in another study that would affect the objectives of this study
- Patients who have already previously used a Medtronic CareLink Monitor.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: 1
Pacemaker Patients
|
Substitution of CareLink Remote Monitoring of Pacemakers for in-clinic pacemaker follow-up visits
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- REMOTE-IPG 2008
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.